{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:49:23Z","timestamp":1782103763913,"version":"3.54.5"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32301234"],"award-info":[{"award-number":["32301234"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20240813172200002"],"award-info":[{"award-number":["JCYJ20240813172200002"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","award":["SZSM202311032"],"award-info":[{"award-number":["SZSM202311032"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The CCL5\/CCR5 axis plays a pivotal role in tumor progression and metastasis. We previously reported CCR5 promoted melanoma EMT and metastasis by upregulating TGF\u03b21 expression via the PI3K\/AKT\/GSK3\u03b2 pathway. However, the full spectrum of downstream events triggered by CCR5 activation remains poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here we employed quantitative phosphoproteomics to profile dynamic phosphorylation events in B16\/F10 cells following CCL5 stimulation at three time points (5, 10 and 30\u00a0min). Moreover, to specifically dissect CCR5-mediated phosphorylation events distinct from other CCL5 receptors, we performed comparative phosphoproteomics between CCR5 knockout and wild type cells at the 5-min stimulation timepoint.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Temporal analysis revealed that CCL5 treatment modulated 256, 134, and 83 phosphosites at these respective time points. In total, 393 phosphosites across 315 phosphoproteins exhibited significant regulation. The comparative phosphoproteomics between CCR5 knockout and wild type cells identified 52 phosphoproteins and their temporal dynamics were illustrated. Gene Ontology enrichment analysis revealed that CCL5\/CCR5 axis participated in various biological processes, particularly cell cycle regulation. Notably, upon CCL5 stimulation, three cell cycle-associated proteins-CEP131, KHDRBS1, and MAPK6-underwent phosphorylation activation, but this activation was remarkably prevented by CCR5 knockout. Overall. these findings provide a comprehensive phosphorylation resource for dissecting the molecular mechanisms underlying CCL5\/CCR5-facilitated tumor progression and identifying potential therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1852022","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:32:40Z","timestamp":1782102760000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative phosphoproteomic profiling of CCL5\/CCR5 signaling cascade in melanoma cells"],"prefix":"10.3389","volume":"16","author":[{"given":"Lifen","family":"Xie","sequence":"first","affiliation":[{"name":"Department of Oncology, The Second Clinical Medical College, Jinan University (Shenzhen People\u2019s Hospital)","place":["Shenzhen, China"]},{"name":"The First Affiliated Hospital, Jinan University","place":["Guangzhou, China"]},{"name":"Department of Chemistry, College of Science, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University Shenzhen","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"He","sequence":"additional","affiliation":[{"name":"Department of Chemistry, College of Science, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Zeng","sequence":"additional","affiliation":[{"name":"Shenzhen Blood Center","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Huang","sequence":"additional","affiliation":[{"name":"Shenzhen Blood Center","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Immunogenetics Laboratory, Shenzhen Blood Center","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","article-title":"CCL5\/CCR5 axis in human diseases and related treatments","volume":"9","author":"Zeng","year":"2022","journal-title":"Genes Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-S1-S9","article-title":"Clinical use of CCR5 inhibitors in HIV and beyond","volume":"9","author":"Gilliam","year":"2011","journal-title":"J Transl Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00204-025-04036-w","article-title":"A silence catalyst: CCL5-mediated intercellular communication in cancer","volume":"99","author":"Hu","year":"2025","journal-title":"Arch Toxicol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-1988-9","article-title":"CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma","volume":"66","author":"Umansky","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3917","article-title":"CCR5 antagonist blocks metastasis of basal breast cancer cells","volume":"72","author":"Velasco-Velazquez","year":"2012","journal-title":"Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-0341","article-title":"CCR5-dependent homing of T regulatory cells to the tumor microenvironment contributes to skin squamous cell carcinoma development","volume":"16","author":"de Oliveira","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e008722","DOI":"10.1136\/jitc-2023-008722","article-title":"CCR5 and CCL5 in metastatic colorectal cancer","volume":"12","author":"Schlechter","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13046-025-03552-y","article-title":"Targeting the CCL5\/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer","volume":"44","author":"Liu","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.07.035","article-title":"CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation","volume":"387","author":"Murooka","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2015.12.004","article-title":"CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer","volume":"77","author":"Ding","year":"2016","journal-title":"BioMed Pharmacother"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035101","article-title":"CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma","volume":"7","author":"Wang","year":"2012","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bcp.2008.11.014","article-title":"CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways","volume":"77","author":"Huang","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1194","article-title":"Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-kappaB-mediated MMP-9 upregulation","volume":"30","author":"Long","year":"2012","journal-title":"Stem Cells"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/path.5207","article-title":"High expression of CCR5 in melanoma enhances epithelial-mesenchymal transition and metastasis via TGFbeta1","volume":"247","author":"Liu","year":"2019","journal-title":"J Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2022.100279","article-title":"Rapid and in-depth coverage of the (phospho-)proteome with deep libraries and optimal window design for dia-PASEF","volume":"21","author":"Skowronek","year":"2022","journal-title":"Mol Cell Proteomics"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-018-0014-9","article-title":"High-throughput and high-sensitivity phosphoproteomics with the EasyPhos platform","volume":"13","author":"Humphrey","year":"2018","journal-title":"Nat Protoc"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1404943111","article-title":"Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1\/CXCR4 in breast cancer stem cells","volume":"111","author":"Yi","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011716","article-title":"Elucidating the CXCL12\/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis","volume":"5","author":"O'Hayre","year":"2010","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024918","article-title":"Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling","volume":"6","author":"Wojcechowskyj","year":"2011","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s13008-025-00145-1","article-title":"Maraviroc enhances Bortezomib sensitivity in multiple myeloma by inhibiting M2 macrophage polarization via PI3K\/AKT\/RhoA signaling pathway in macrophages","volume":"20","author":"Yang","year":"2025","journal-title":"Cell Div"},{"key":"B21","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41419-019-1778-8","article-title":"Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stability","volume":"10","author":"Kim","year":"2019","journal-title":"Cell Death Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10075","article-title":"p38- and MK2-dependent signalling promotes stress-induced centriolar satellite remodelling via 14-3-3-dependent sequestration of CEP131\/AZI1","volume":"6","author":"Tollenaere","year":"2015","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-023-10145-8","article-title":"Sam68 is a druggable vulnerability point in cancer stem cells","volume":"43","author":"da Silva","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-022-00853-0","article-title":"The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer","volume":"29","author":"Pieraccioli","year":"2022","journal-title":"Nat Struct Mol Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600467","article-title":"Scaffolding by ERK3 regulates MK5 in development","volume":"23","author":"Schumacher","year":"2004","journal-title":"EMBO J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600489","article-title":"Activation of MK5\/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway","volume":"23","author":"Seternes","year":"2004","journal-title":"EMBO J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20091604","article-title":"C-terminal domain phosphorylation of ERK3 controlled by Cdk1 and Cdc14 regulates its stability in mitosis","volume":"428","author":"Tanguay","year":"2010","journal-title":"Biochem J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2020.01.009","article-title":"The CCR5 antagonist maraviroc causes remission of pancreatic cancer liver metastasis in nude rats based on cell cycle inhibition and apoptosis induction","volume":"474","author":"Huang","year":"2020","journal-title":"Cancer Lett"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2005.10.008","article-title":"Pitavastatin-induced downregulation of CCR2 and CCR5 in monocytes is associated with the arrest of cell-cycle in S phase","volume":"187","author":"Fujino","year":"2006","journal-title":"Atherosclerosis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s13402-018-0415-3","article-title":"CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer","volume":"42","author":"Pervaiz","year":"2019","journal-title":"Cell Oncol Dordr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.004867","article-title":"Polo-like kinase 4 maintains centriolar satellite integrity by phosphorylation of centrosomal protein 131 (CEP131)","volume":"294","author":"Denu","year":"2019","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.15.8951","article-title":"ERK3 is a constitutively nuclear protein kinase","volume":"271","author":"Cheng","year":"1996","journal-title":"J Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.181743","article-title":"Identification of the atypical MAPK Erk3 as a novel substrate for p21-activated kinase (Pak) activity","volume":"286","author":"De la Mota-Peynado","year":"2011","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1060555","article-title":"Phosphoproteomic mapping of CCR5 and ACKR2 signaling properties","volume":"9","author":"Vacchini","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.04.015","article-title":"Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages","volume":"331","author":"Di Marzio","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-020-0441-4","article-title":"CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways","volume":"100","author":"Kodama","year":"2020","journal-title":"Lab Invest"},{"key":"B37","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1089\/wound.2014.0568","article-title":"Chemokines in wound healing and as potential therapeutic targets for reducing cutaneous scarring","volume":"4","author":"Rees","year":"2015","journal-title":"Adv Wound Care New Rochelle"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/art.27755","article-title":"The CCL5\/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts","volume":"62","author":"Tang","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-015-0186-1","article-title":"CCR5 blockade suppresses melanoma development through inhibition of IL-6-Stat3 pathway via upregulation of SOCS3","volume":"38","author":"Tang","year":"2015","journal-title":"Inflammation"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0915","article-title":"CCR5 governs DNA damage repair and breast cancer stem cell expansion","volume":"78","author":"Jiao","year":"2018","journal-title":"Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.104059","article-title":"The centriolar satellite protein Cep131 is important for genome stability","volume":"125","author":"Staples","year":"2012","journal-title":"J Cell Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1181","article-title":"Cdk1-mediated threonine phosphorylation of Sam68 modulates its RNA binding, alternative splicing activity and cellular functions","volume":"50","author":"Malki","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.5735","article-title":"miR-98 inhibits cell proliferation and induces cell apoptosis by targeting MAPK6 in HUVECs","volume":"15","author":"Hu","year":"2018","journal-title":"Exp Ther Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1852022\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:32:45Z","timestamp":1782102765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1852022\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":43,"alternative-id":["10.3389\/fonc.2026.1852022"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1852022","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"article-number":"1852022"}}